Page last updated: 2024-08-23

avermectin and Disease Models, Animal

avermectin has been researched along with Disease Models, Animal in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azevedo, R; Mendes, AM; Prudêncio, M	1
Ariztia, EV; Ashworth, A; Bansal, N; Brough, R; Christova, R; Farias, E; Frankum, J; Gil, V; Howell, L; Kwon, YJ; Leibovitch, BA; Lord, CJ; Mezei, M; Petrie, K; Sbirkov, Y; Sharma, R; Waxman, S; Yang, S; Zelent, A; Zeng, L; Zhou, MM	1

Other Studies

2 other study(ies) available for avermectin and Disease Models, Animal

Article	Year
Inhibition of Plasmodium sporogonic stages by ivermectin and other avermectins. Parasites & vectors, 2019, Nov-21, Volume: 12, Issue:1 Topics: Animals; Antiparasitic Agents; Disease Models, Animal; Disease Transmission, Infectious; Ivermectin; Malaria; Mice, Inbred BALB C; Oocysts; Plasmodium berghei	2019
Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer. Molecular cancer therapeutics, 2015, Volume: 14, Issue:8 Topics: Animals; Antigens, CD; Antiparasitic Agents; Cadherins; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Ivermectin; Mice; Models, Molecular; Molecular Conformation; Protein Interaction Domains and Motifs; Repressor Proteins; Triple Negative Breast Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays	2015

Article

Year

Inhibition of Plasmodium sporogonic stages by ivermectin and other avermectins.

Parasites & vectors, 2019, Nov-21, Volume: 12, Issue:1

Topics: Animals; Antiparasitic Agents; Disease Models, Animal; Disease Transmission, Infectious; Ivermectin; Malaria; Mice, Inbred BALB C; Oocysts; Plasmodium berghei

2019

Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.

Molecular cancer therapeutics, 2015, Volume: 14, Issue:8

Topics: Animals; Antigens, CD; Antiparasitic Agents; Cadherins; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Ivermectin; Mice; Models, Molecular; Molecular Conformation; Protein Interaction Domains and Motifs; Repressor Proteins; Triple Negative Breast Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays

2015